Skip to main content

Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia.

Journal articles  - Journal Article
Chan, LC; Lee, HK; Wang, L; Wang, H; Filler, SG; Ciranna, A; Abdelhady, W; Xiong, YQ; Li, L; Gonzales, RA; Ruffin, F; Fowler, VG; Bayer, AS ...
Published in: Antibiotics (Basel)
March 25, 2026

BACKGROUND: Staphylococcus aureus bacteremia (SAB) is a common and life-threatening bloodstream infection often caused by methicillin-resistant SA (MRSA) isolates. Up to 35% of SAB patients fail to clear infection with gold-standard anti-MRSA antibiotics, even if the isolate meets susceptibility breakpoints in conventional assays in vitro. Such outcomes are termed persistent and may involve small colony variant (SCV) adaptation of SA in vivo. METHODS: In this study, we assessed virulence phenotypes and mechanisms in persistent (PB) vs. resolving (RB) MRSA isolates from SAB. RESULTS: Overall, PB isolates caused less hemolysis or biofilm formation than RB isolates, but proteolysis was equivalent. Attenuation of these virulence phenotypes increased longitudinally during the course of SAB. Although PB vs. RB isolates had similar human endothelial cell invasion rates, PB isolates more frequently formed SCVs intracellularly and inversely correlated with pH. Study PB and RB isolates exhibited distinct susceptibilities to prototypic human host defense peptides (HDPs), which were influenced by antibiotics and pH. Furthermore, mechanistic signatures of HDPs differed between PB and RB isolates. CONCLUSIONS: Together, these results reveal that MRSA isolates from PB vs. RB outcomes of SAB have differential virulence profiles that suggest coordinated immune subversion in PB. Understanding MRSA adaptations that promote persistence in SAB may enable innovative agents and strategies to address these challenging infections.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Antibiotics (Basel)

DOI

ISSN

2079-6382

Publication Date

March 25, 2026

Volume

15

Issue

4

Location

Switzerland

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chan, L. C., Lee, H. K., Wang, L., Wang, H., Filler, S. G., Ciranna, A., … MRSA Systems Immunobiology Group (MSIG). (2026). Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia. Antibiotics (Basel), 15(4). https://doi.org/10.3390/antibiotics15040332
Chan, Liana C., Hong K. Lee, Ling Wang, Huiyuan Wang, Scott G. Filler, Alexandra Ciranna, Wessam Abdelhady, et al. “Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia.Antibiotics (Basel) 15, no. 4 (March 25, 2026). https://doi.org/10.3390/antibiotics15040332.
Chan LC, Lee HK, Wang L, Wang H, Filler SG, Ciranna A, et al. Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia. Antibiotics (Basel). 2026 Mar 25;15(4).
Chan, Liana C., et al. “Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia.Antibiotics (Basel), vol. 15, no. 4, Mar. 2026. Pubmed, doi:10.3390/antibiotics15040332.
Chan LC, Lee HK, Wang L, Wang H, Filler SG, Ciranna A, Abdelhady W, Xiong YQ, Li L, Gonzales RA, Ruffin F, Fowler VG, Bayer AS, Proctor RA, Yeaman MR, MRSA Systems Immunobiology Group (MSIG). Virulence Phenotypes Differentiate Persistent vs. Resolving Isolates of Human Staphylococcus aureus Bacteremia. Antibiotics (Basel). 2026 Mar 25;15(4).

Published In

Antibiotics (Basel)

DOI

ISSN

2079-6382

Publication Date

March 25, 2026

Volume

15

Issue

4

Location

Switzerland

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences